Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia

Journal of Alzheimer's Disease

Volumn 54, Issue 4, 2016, Pages 1385-1393

  Karch, André ^a,b,c   Llorens, Franc ^b,d   Schmitz, Matthias ^b,d   Arora, Amandeep Singh ^b,d   Zafar, Saima ^b   Lange, Peter ^b   Schmidt, Christian ^b   Zerr, Inga ^b,d  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c Center for Experimental and Clinical Infection Research   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Alzheimer's disease; amyloid beta; biomarker; cerebrospinal fluid; Creutzfeldt Jakob disease; dementia; tau

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; TAU PROTEIN; AMYLOID BETA PROTEIN;

ADULT; AGE; AGED; ALZHEIMER DISEASE; APOE E4 GENE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CODON; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ELISA KIT; FEMALE; GENE; GENETIC MARKER; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRNP GENE; RAPIDLY PROGRESSIVE ALZHEIMER DISEASE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SPORADIC CREUTZFELDT JAKOB DISEASE; CEREBROSPINAL FLUID; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE EXACERBATION; GENETICS; MIDDLE AGED;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOMARKERS; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TAU PROTEINS;

EID: 84992077419     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160267     Document Type: Article

References (24)

1. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimers disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol 6, 734-746
2. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132, 2659-2668
3. Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S (2002) Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 58, 192-197
4. Engelborghs S, De Vreese K, Van Casteele T, Vanderstichele H, Van Everbroeck B, Cras P, Martin JJ, Vanmechelen E, De Deyn PP (2008) Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol Aging 29, 1143-1159
5. Schoonenboom NS, Reesink FE, Verwey NA, Kester MI, Teunissen CE, van Ven PM, Pijnenburg YA, Blankenstein MA, Rozemuller AJ, Scheltens P, van der Flier WM (2012) Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 78, 47-54
6. Llorens F, Schmitz M, Karch A, Cramm M, Lange P, Gherib K, Varges D, Schmidt C, Zerr I, Stoeck K (2016) Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia. Alzheimers Dement 12, 577-589
7. Varges D, Jung K, Gawinecka J, Heinemann U, Schmitz M, von Ahsen N, Krasnianski A, Armstrong VW, Zerr I (2011) Amyloid-beta 1-42 levels are modified by apolipoprotein E epsilon4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimers disease. J Alzheimers Dis 23, 717-726
8. Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P (1998) High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol 55, 937-945
9. Karch A, Hermann P, Ponto C, Schmitz M, Arora A, Zafar S, Llorens F, Muller-Heine A, Zerr I (2015) Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease. Neurobiol Aging 36, 1964-1968
10. Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I (2007) Creutzfeldt-Jakob disease in Germany: A prospective 12-year surveillance. Brain 130, 1350-1359
11. Schmidt C, Karch A, Artjomova S, Hoeschel M, Zerr I (2013) Pre-progression rates in Alzheimers disease revisited. J Alzheimers Dis 35, 451-454
12. Schmidt C, Haik S, Satoh K, Rabano A, Martinez-Martin P, Roeber S, Brandel JP, Calero-Lara M, de Pedro-Cuesta J, Laplanche JL, Hauw JJ, Kretzschmar H, Zerr I (2012) Rapidly progressive Alzheimers disease: A multicenter update. J Alzheimers Dis 30, 751-756
13. Schmidt C, Redyk K, Meissner B, Krack L, von Ahsen N, Roeber S, Kretzschmar H, Zerr I (2010) Clinical features of rapidly progressive Alzheimers disease. Dement Geriatr Cogn Disord 29, 371-378
14. Schmidt C, Wolff M, Weitz M, Bartlau T, Korth C, Zerr I (2011) Rapidly progressive Alzheimer disease. Arch Neurol 68, 1124-1130
15. Mollenhauer B, Bibl M, Wiltfang J, Steinacker P, Ciesielczyk B, Neubert K, Trenkwalder C, Otto M (2006) Total tau protein, phosphorylated tau (181p) protein, betaamyloid( 1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewybodies. Clin Chem Lab Med 44, 192-195
16. Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S, Oberdieck C, Bodemer M, Poser S, Kretzschmar HA (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105, 244-252
17. Burger nee Buch K, Padberg F, Nolde T, Teipel SJ, Stubner S, Haslinger A, Schwarz MJ, Sunderland T, Arai H, Rapoport SI, Moller HJ, Hampel H (1999) Cerebrospinal fluid tau protein shows a better discrimination in young old (70 years) than in old old patients with Alzheimers disease compared with controls. Neurosci Lett 277, 21-24
18. Humpel C (2011) Identifying and validating biomarkers for Alzheimers disease. Trends Biotechnol 29, 26-32
19. Sjogren M, Davidsson P, TullbergM,Minthon L,Wallin A, Wikkelso C, Granerus AK, Vanderstichele H, Vanmechelen E, Blennow K (2001) Both total and phosphorylated tau are increased in Alzheimers disease. J Neurol Neurosurg Psychiatry 70, 624-630
20. Sjogren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelso C, Skoog I, Wallin A, Wahlund LO, Marcusson J, Nagga K, Andreasen N, Davidsson P, Vanmechelen E, Blennow K (2001) Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: Establishment of reference values. Clin Chem 47, 1776-1781
21. Parchi P, Castellani R, Capellari S, Ghetti B,Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39, 767-778
22. Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Saanchez-Valle R, Mitrovaa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichova D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens AC, van Duijn CM, Zerr I (2006) CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 67, 637-643
23. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F (1999) Sporadic Creutzfeldt-Jakob disease: Cooccurrence of different types of PrP(Sc) in the same brain. Neurology 53, 2173-2176
24. Mattsson N, Rosen E, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek MM, Olde Rikkert M, Tsolaki M, Mulugeta E, Aarsland D, Visser PJ, Schroder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Wallin A, Eriksdotter-Jonhagen M, Minthon L, Winblad B, Blennow K, Zetterberg H (2012) Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology 78, 468-476